Krystal Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.About KRYS
Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK.
CEOKrish S. Krishnan
CEOKrish S. Krishnan
Employees275
Employees275
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2016
Founded2016
Employees275
Employees275
KRYS Key Statistics
Market cap4.13B
Market cap4.13B
Price-Earnings ratio34.46
Price-Earnings ratio34.46
Dividend yield—
Dividend yield—
Average volume424.78K
Average volume424.78K
High today$143.09
High today$143.09
Low today$140.70
Low today$140.70
Open price$141.95
Open price$141.95
Volume118.02K
Volume118.02K
52 Week high$219.34
52 Week high$219.34
52 Week low$122.80
52 Week low$122.80
KRYS News
Simply Wall St 13h
Krystal Biotech shareholder returns have been strong, earning 249% in 5 yearsWhile Krystal Biotech, Inc. ( ) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 16%...
TipRanks 5d
Krystal Biotech initiated with a Buy at Clear StreetClear Street analyst Bill Maughan initiated coverage of Krystal Biotech (KRYS) with a Buy rating and $190 price target Krystal’s first commercial product, Vyjuv...
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%
People also own
Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.